Gut–brain axis

May 19, 2020

ProDigest and CosmosID Announce a Winner for the 'Gut Microbiome Therapeutic Innovation' Challenge

Jan 06, 2020

The Human Microbiome Market (3rd Edition), 2019-2030: Focus on Therapeutics (including Gut-Brain Axis Targeting Drugs), Diagnostics and Fecal Microbiota Therapies

Dec 30, 2019

Gen-Next Probiotics & Microbiome Congress: Major Breakthroughs, Challenges, and Potential Research Areas - 2-Day Event in San Diego, CA, United States - February 6-7, 2020

Sep 10, 2019

ENT-01, Currently in Human Trials, Rejuvenates Aging Nervous System

Sep 05, 2019

Amare Adds Breakthrough Products to Its Mental Wellness Lineup

Jun 24, 2019

Enterin's DEMET Study Enrolls First Patient With Parkinson's Disease Dementia (PDD)

May 28, 2019

Neuraxpharm, the European CNS Specialist, Launches First Probiotic Product PS128(TM)

May 22, 2019

Bened Biomedical Co., Ltd.: Psychobiotic PS128(TM) found to be a potential solution for Autism Spectrum Disorder (ASD) and Attention Deficit Hyperactivity Disorder (ADHD)

May 07, 2019

Foundation Calls for U.S. Research Proposals to Study Links between Gut Microbiota and the Brain

Jan 29, 2019

The Biocodex Microbiota Foundation Awards U.S. Researcher a Grant to Study Gut Flora and Hypertension

Jan 09, 2019

KARMET Study Begins Enrollment

Feb 22, 2018

Kallyope Inc. Announces $66M Series B Financing to Advance Programs Targeting the Gut-Brain Axis